Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Casesallergy-and-immunology

Paeds Cases · allergy-and-immunology

Explaining a false penicillin-allergy label and the delabelling pathway — OSCE

Communication and structured-discussion OSCE on a 6-year-old with community-acquired pneumonia and a long-standing, unverified penicillin-allergy label (a childhood rash during a viral illness). The candidate must explain to a parent that the label is most likely false, outline the safe delabelling pathway with PEN-FAST risk stratification and a supervised oral amoxicillin challenge, explain the stewardship benefit of restoring first-line penicillin, and address the parent's surprise and concerns about challenging a child they were told was allergic.

osce communication delabelling antibiotic stewardship
On this page & tools

Target exams

MRCPCH ClinicalRACP DCERCPSC PediatricsABP General Pediatrics

Target exams

MRCPCH ClinicalRACP DCERCPSC PediatricsABP General Pediatrics
Prompt
A 6-year-old girl with community-acquired pneumonia has carried a penicillin-allergy label since age 2, after a maculopapular rash on day 5 of amoxicillin for a viral upper-respiratory infection, with no swelling, breathing difficulty, blistering or mucosal involvement. The label has never been evaluated. She now needs amoxicillin. The candidate must explain to the parent that the label is most likely false, outline the safe delabelling pathway (structured history, PEN-FAST, supervised oral challenge), explain the benefit of restoring first-line penicillin, and address the parent's concern about challenging a child they were told was allergic.

Candidate instructions (8-minute station)

You are the paediatric registrar in the clinic. A 6-year-old girl has community-acquired pneumonia and needs amoxicillin. She has carried a "penicillin allergy" label since age 2, when she developed a widespread maculopapular rash on day 5 of amoxicillin given for a viral illness; there was no swelling, breathing difficulty, blistering or mucosal involvement, and the label has never been evaluated. [3]

Your tasks are: [10]

  1. Explain to the parent that the penicillin-allergy label is most likely false, and why, in plain language. [3]
  2. Outline the safe delabelling pathway — a structured history, a risk check (PEN-FAST), and a supervised oral amoxicillin challenge. [2]
  3. Explain the benefit of removing the label: restoring first-line penicillin and avoiding broader-spectrum, more problematic antibiotics. [9]
  4. Address the parent's concern and surprise about challenging a child they were told was allergic. [1]

You are not expected to perform the challenge yourself in the station — you are explaining the pathway and the plan. Flag that the challenge is done under observation with the capacity to treat any reaction, so it is safe. [1]

Examiner prompt to the actor (parent)

"But she's been told she's allergic to penicillin her whole life — surely that's dangerous to test now? And if it wasn't an allergy, why did someone put it on her record? I don't want her to have a reaction just to prove a point." [10]

Marking domains

  • Frame and explanation (3): explains clearly and in plain language that most childhood penicillin-allergy labels are not real (more than 90% cannot be confirmed), that a rash with a viral illness is the commonest reason for a false label, and that the label has simply never been checked — without dismissing the parent's concern. [3]
  • The delabelling pathway (3): outlines the safe, structured pathway — history, a PEN-FAST risk check to confirm she is low-risk, and a supervised oral amoxicillin challenge under observation with the capacity to treat any reaction; reassures the parent that this is an evidence-based, safe process supported by the PALACE trial. [2] [1]
  • The benefit of removing the label (2): explains that removing the label restores the safest, most effective first-line antibiotic for this pneumonia and for the rest of her life, and avoids broader-spectrum, more problematic antibiotics — the antibiotic-stewardship benefit. [9]
  • Communication and empathy (2): acknowledges the parent's worry and the confusing record without defensiveness, uses plain language, checks understanding, and invites questions; does not overwhelm. [10]

Model answer — the explanatory script

"Thank you for coming in, and that's a really reasonable question. Let me explain why we think the label is most likely not a true allergy, and how we can check it safely." [3]

"When your daughter was two and had that rash, she was being treated with amoxicillin for what was almost certainly a viral illness. The rash you saw is exactly the kind of rash that viral illnesses cause in children — and it's also the classic situation where a rash gets blamed on the antibiotic when the virus was the real cause. More than nine out of ten children who carry a penicillin-allergy label turn out not to be allergic at all when we test them properly. So the label on her record has almost certainly never been a true allergy — it just got put there years ago and was never checked." [3] [10]

"Now, here's the safe way we check it. First, I take a careful history of exactly what happened — which we've just done — and that tells me she's low-risk. Then we use a simple checklist called PEN-FAST that confirms she's in the low-risk group. And because she's low-risk, the next step is to give her a dose of amoxicillin here, under close observation, with the team and the medicines ready in the very unlikely event she reacts. A large study called the PALACE trial showed this is just as safe as the old skin-test-first approach, and much quicker. So she's not having a reaction to prove a point — she's having a carefully watched test that, in almost every case, shows the child is fine." [2] [1]

"Why does it matter? Because if we remove the label, your daughter gets the best first-line antibiotic for this pneumonia — amoxicillin — and for every infection she has for the rest of her life. Carrying the label means she gets pushed onto other antibiotics that are broader, can have more side-effects, and contribute to antibiotic resistance. Removing a label that was never real gives her back the safest option." [9]

"And I completely understand it feels confusing that it was on her record at all — that happens very often, and it's exactly why we now make a point of checking these labels rather than just carrying them forever. If she tolerates the test dose, we update every part of her record — the hospital, the pharmacy, your own records, and your GP — so the label is gone for good. How does that sound, and what questions can I answer for you?" [10]

References

  1. [1]Copaescu AM; Vogrin S; James F; et al Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial. JAMA Intern Med, 2023.PMID 37459086
  2. [2]Trubiano JA; Vogrin S; Chua KYL; et al Development and Validation of a Penicillin Allergy Clinical Decision Rule. JAMA Intern Med, 2020.PMID 32176248
  3. [3]Wong T; Atkinson A; t'Jong G; et al Beta-lactam allergy in the paediatric population. Paediatr Child Health, 2020.PMID 32042244
  4. [9]Joerger T; Taylor MG; Li Y; et al Impact of Penicillin Allergy Labels on Children Treated for Outpatient Respiratory Infections. J Pediatric Infect Dis Soc, 2023.PMID 36461664
  5. [10]Stone CA Jr; Trubiano J; Coleman DT; et al The challenge of de-labeling penicillin allergy. Allergy, 2020.PMID 31049971